HC Biopharma Inc.
HC Biopharma Inc.
Explore linked clinical trials.9 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A Randomized, Double-Blind, Positive-Controlled, Parallel Pharmacokinetic Phase I Clinical Study of Cetuximab Injection Versus Erbitux in Healthy Male Subjects | Bioequivalence; Cetuximab; Healthy Volunteers; Pharmacokinetics | Recruiting | Phase 1 | 2026-09-10 | NCT07813468 | |
| A Phase Ib Clinical Study on the Safety and Efficacy of HC010 Combinations in Advanced Solid Tumors | Advanced Solid Tumor Cancer | Recruiting | Phase 1 | 2026-03-17 | NCT07477743 | |
| A Phase Ib Clinical Study on the Safety and Efficacy of HC010 Combined With Chemotherapy in Lung Cancer | Advanced Solid Tumor Cancer | Recruiting | Phase 1 | 2026-02-02 | NCT07381829 | |
| The Safety, Tolerability, Pharmacokinetics, Immunogenicity and Preliminary Efficacy of HC022 Injection in Subjects With SLE/CLE | Skin and Connective Tissue Diseases, autoimmune disease, connective tissue disorder, cutaneous lupus erythematosus, immune system disorder, skin disorder, systemic lupus erythematosus | Not yet recruiting | Phase 1 | 2026-01-28 | NCT07306585 | |
| HC010 in First-line PD-L1 Positive Advanced NSCLC Patients | non-small cell lung carcinoma | Recruiting | Phase 2 | 2025-12-17 | NCT07169552 | |
| Study of HC006 in Combination With a PD-1 Inhibitor in Patients With Advanced Solid Tumors | Advanced Cancer | Recruiting | Phase 1 | 2025-07-17 | NCT06963814 | |
| A Phase I Study to Evaluate the Safety, Pharmacokinetics and Antitumor Activity of HC010 in Patients With Advanced Solid Tumors | Digestive System Diseases, Digestive System Neoplasms, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Genital Diseases, Liver Neoplasms, Neoplasms by Histologic Type, Neoplasms by Site, Thoracic Neoplasms, Urogenital Diseases, Urogenital Neoplasms, Uterine Cervical Neoplasms, adenocarcinoma, bronchial neoplasm, bronchogenic carcinoma, carcinoma, cervix disorder, colonic disorder, colorectal neoplasm, digestive system disorder, digestive system neoplasm, epithelial neoplasm, female reproductive system disorder, female reproductive system neoplasm, hepatocellular carcinoma, intestinal disorder, liver disorder, lung disorder, lung neoplasm, neoplasm, non-small cell lung carcinoma, rectal disorder, respiratory system disorder, respiratory tract neoplasm, uterine disorder | Recruiting | Phase 1 | 2025-05-13 | NCT06307925 | |
| A Study of HC006 in Subjects With Advanced Solid Tumors | Advanced Solid Tumor | Recruiting | Phase 1 | 2025-05-06 | NCT06304571 | |
| Safety, Tolerability, and Pharmacokinetics of Single Doses of HC022 in Healthy Subjects. | Skin and Connective Tissue Diseases, autoimmune disease, connective tissue disorder, immune system disorder, systemic lupus erythematosus | Recruiting | Phase 1 | 2025-04-17 | NCT06657703 |